Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1969 2
1970 1
1971 2
1972 3
1973 1
1974 4
1975 8
1976 6
1977 5
1978 6
1979 8
1980 8
1981 7
1982 3
1983 3
1984 5
1985 2
1986 4
1987 4
1988 2
1989 4
1990 3
1991 8
1992 5
1993 2
1994 12
1995 8
1996 14
1997 3
1998 6
1999 7
2000 4
2001 5
2002 8
2003 3
2004 4
2005 6
2006 6
2008 7
2009 2
2014 6
2015 6
2016 4
2017 1
2018 1
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

213 results
Results by year
Filters applied: . Clear all
Page 1
Autophagy inhibitors.
Pasquier B. Pasquier B. Cell Mol Life Sci. 2016 Mar;73(5):985-1001. doi: 10.1007/s00018-015-2104-y. Epub 2015 Dec 11. Cell Mol Life Sci. 2016. PMID: 26658914 Review.
In Vitro Characterization of VPS34 Lipid Kinase Inhibition by Small Molecules.
Fassy F, Dureuil C, Lamberton A, Mathieu M, Michot N, Ronan B, Pasquier B. Fassy F, et al. Among authors: Pasquier B. Methods Enzymol. 2017;587:447-464. doi: 10.1016/bs.mie.2016.09.070. Epub 2016 Nov 29. Methods Enzymol. 2017. PMID: 28253972 Review.
Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica.
Pasquier B, Borisow N, Rasche L, Bellmann-Strobl J, Ruprecht K, Niendorf T, Derfuss TJ, Wuerfel J, Paul F, Sinnecker T. Pasquier B, et al. Neurol Neuroimmunol Neuroinflamm. 2019 Mar 7;6(3):e541. doi: 10.1212/NXI.0000000000000541. eCollection 2019 May. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 30882018 Free PMC article.
[Nontumoral epileptogenic lesions].
Varlet P, Pasquier B, Miquel C, Beuvon F, Daumas-Duport C. Varlet P, et al. Among authors: Pasquier B. Neurochirurgie. 2008 May;54(3):159-65. doi: 10.1016/j.neuchi.2008.02.038. Epub 2008 Apr 28. Neurochirurgie. 2008. PMID: 18440566 Review. French.
Discovery of (2S)-8-[(3R)-3-methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: a novel potent and selective inhibitor of Vps34 for the treatment of solid tumors.
Pasquier B, El-Ahmad Y, Filoche-Rommé B, Dureuil C, Fassy F, Abecassis PY, Mathieu M, Bertrand T, Benard T, Barrière C, El Batti S, Letallec JP, Sonnefraud V, Brollo M, Delbarre L, Loyau V, Pilorge F, Bertin L, Richepin P, Arigon J, Labrosse JR, Clément J, Durand F, Combet R, Perraut P, Leroy V, Gay F, Lefrançois D, Bretin F, Marquette JP, Michot N, Caron A, Castell C, Schio L, McCort G, Goulaouic H, Garcia-Echeverria C, Ronan B. Pasquier B, et al. J Med Chem. 2015 Jan 8;58(1):376-400. doi: 10.1021/jm5013352. Epub 2014 Nov 26. J Med Chem. 2015. PMID: 25402320
SLAM-associated protein favors the development of iNKT2 over iNKT17 cells.
Michel ML, Lenoir C, Massot B, Diem S, Pasquier B, Sawa S, Rignault-Bricard R, Lehuen A, Eberl G, Veillette A, Leite-de-Moraes M, Latour S. Michel ML, et al. Among authors: Pasquier B. Eur J Immunol. 2016 Sep;46(9):2162-74. doi: 10.1002/eji.201646313. Epub 2016 Jul 22. Eur J Immunol. 2016. PMID: 27338553 Free article.
213 results
Jump to page
Feedback